Sanford Burnham Prebys Scientists Identify New Genetic Progeria Syndrome Linking Premature Aging to Cognitive Decline

Sanford Burnham Prebys researchers identify a mutation in the IVNS1ABP gene causing a rare syndrome of accelerated aging and progressive cognitive decline.

By: AXL Media

Published: Mar 25, 2026, 6:29 AM EDT

Source: Information for this report was sourced from Sanford Burnham Prebys

Defining a New Frontier in Progeria Research

The landscape of rare genetic disorders has expanded with the discovery of a unique condition that merges the physical hallmarks of premature aging with severe intellectual impairment. Researchers at the Sanford Burnham Prebys Medical Discovery Institute utilized an innovative combination of genome sequencing and cellular reprogramming to isolate the cause of symptoms in a family of patients exhibiting whitened hair and motor skill loss during their teenage years. Unlike classic progeria syndromes, such as Hutchinson-Gilford, where the brain is often spared from accelerated decay, this new disease is defined by a progressive loss of neurological function and intellectual capacity.

Mapping the IVNS1ABP Gene Mutation

Through advanced genomic mapping of recessive traits, the investigative team traced the origins of the disorder to a mutation in the IVNS1ABP gene. This specific genetic sequence provides the instructions for a protein that binds to influenza virus non-structural protein-1, a component previously unlinked to the biology of human aging or neuropathy. Dr. Su-Chun Zhang, the study's senior author, noted that the discovery was unexpected, as the gene had never before been implicated in age-related disease. The identification of this "mystery" mutation provides a new molecular target for understanding how the body maintains its chronological and neurological integrity.

The Rise of Zombie-Like Senescent Cells

To observe the disease’s progression in real-time, the scientists reprogrammed patient skin cells into induced pluripotent stem cells and eventually into neural progenitor cells. Under microscopic observation, the mutated cells exhibited significantly lethargic growth compared to healthy controls, eventually entering a state known as cellular senescence. Often described as "zombie cells," these units cease to divide but remain metabolically active, secreting inflammatory signals that damage surrounding tissue. The researchers identified three distinct markers of genomic injury in these cells, alongside an increased expression of the cell cycle inhibitor gene CDKN2A.